One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma. Bispecific antibodies offer a “targeted and effective alternative” for the ...
ExtremeTech on MSN
Scientists Identify Antibodies That Neutralize the Virus Behind COVID-19
Scientists have identified a new pair of antibodies that could fend off multiple COVID-19 variants. Found in people who ...
The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health ...
Researchers at Colorado State University have determined how to use artificial intelligence to modify antibodies so they act ...
Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer. In a study published in Nature Communications, researchers used ...
Bispecific antibodies first reached patients as cancer treatments, but a growing number of companies are working to expand these therapies to autoimmune diseases. Sanofi is adding a new contender, ...
A major answer to the question of when — and how — Americans can return to public places like work and school could depend on something called an antibody test, a blood test that determines whether ...
(Reuters) - A newly discovered type of immune system protein or antibody can neutralize H5N1 avian influenza and other, seasonal viruses. Here are some facts about influenza: * Seasonal influenza ...
The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...
Dr. Amany Keruakous discussed how bispecific antibodies for multiple myeloma work by simultaneously targeting cancer cells and T cells. Dr. Amany Keruakous sat down for an interview with CURE, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results